Table 2.
Standardized prevalence pmp of patients receiving KRT across countries in Europe in 2008–17
| Annual percentage change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Time perioda | Time perioda | Time perioda |
| Austria | 1077.6 | 1061.2 | 1053.9 | 1049.6 | 1067.5 | 1085.9 | 1089.6 | 1086.1 | 1083.0 | 1081.1 | 2008–11: −0.73 (−1.47; 0.01) | 2011–14: 1.36 (−0.15; 2.88) | 2014–17: −0.43 (−1.17; 0.32) |
| Belgium—Dutch-speaking | 1121.2 | 1155.0 | 1171.1 | 1185.2 | 1197.0 | 1202.4 | 1207.6 | 1213.3 | 1214.3 | 1223.3 | 2008–11: 1.87* (1.29; 2.45) | 2011–17: 0.44* (0.25; 0.63) | |
| Belgium—French-speaking | 1187.6 | 1225.2 | 1255.3 | 1280.2 | 1311.0 | 1332.6 | 1355.0 | 1384.3 | 1414.7 | 1435.8 | 2008–10: 2.85* (1.99; 3.72) | 2010–17: 1.94 * (1.82; 2.05) | |
| Denmark | 879.1 | 887.3 | 885.2 | 889.8 | 900.2 | 902.4 | 925.2 | 928.4 | 939.8 | 955.1 | 2008–11: 0.27 (−0.65; 1.2) | 2011–17: 1.17* (0.85; 1.48) | |
| Finland | 789.8 | 798.3 | 810.4 | 813.2 | 815.5 | 823.4 | 830.2 | 841.8 | 869.7 | 884.6 | 2008–14: 0.75* (0.46; 1.04) | 2014–17: 2.19* (1.32; 3.07) | |
| France | 1121.9 | 1154.0 | 1187.7 | 1211.9 | 1223.0 | 1249.4 | 1279.9 | 1305.3 | 1327.6 | 1352.4 | 2008–17: 2.03* (1.89; 2.17) | ||
| Greece | 1044.5 | 1067.8 | 1070.6 | 1081.1 | 1112.6 | 1134.5 | 1151.3 | 1165.2 | 1201.0 | 1221.3 | 2008–17: 1.75* (1.56; 1.94) | ||
| Iceland | 634.2 | 655.7 | 721.1 | 789.8 | 817.8 | 809.0 | 785.0 | 740.9 | 749.6 | 863.0 | 2008–12: 7.50* (2.87; 12.34) | 2012–15: 4.09 (−16.56; 10.24) | 2015–17: 6.94 (−6.96; 22.92) |
| Norway | 922.4 | 951.2 | 964.7 | 976.2 | 986.8 | 994.8 | 1008.6 | 1014.9 | 1022.3 | 1042.2 | 2008–10: 2.22* (1.03; 3.42) | 2010–17: 1.02* (0.86; 1.17) | |
| Spain—Andalusia | 1086.7 | 1109.0 | 1131.4 | 1142.7 | 1180.4 | 1202.3 | 1220.1 | 1227.6 | 1253.3 | 1274.8 | 2008–17: 1.78* (1.63; 1.94) | ||
| Spain—Aragon | 1009.7 | 1002.6 | 1038.4 | 1048.9 | 1088.4 | 1099.5 | 1105.6 | 1109.6 | 1135.6 | 1182.1 | 2008–17: 1.71* (1.39; 2.02) | ||
| Spain—Asturias | 895.6 | 911.5 | 914.1 | 941.5 | 954.6 | 1001.0 | 1015.8 | 1032.7 | 1099.0 | 1126.7 | 2008–17: 2.62* (2.19; 3.04) | ||
| Spain—Basque country | 977.1 | 1005.2 | 1010.9 | 1032.5 | 1059.3 | 1073.3 | 1079.2 | 1089.0 | 1112.2 | 1118.5 | 2008–17: 1.49* (1.29; 1.69) | ||
| Spain—Cantabria | 869.1 | 888.8 | 914.2 | 935.2 | 950.7 | 963.7 | 970.9 | 987.9 | 1016.6 | 1028.8 | 2008–11: 2.42* (1.37; 3.47) | 2011–17: 1.59* (1.23; 1.94) | |
| Spain—Castile and Léon | 907.7 | 916.6 | 922.9 | 935.4 | 955.8 | 960.9 | 978.2 | 994.8 | 1022.3 | 1055.9 | 2008–15: 1.33* (1.11; 1.54) | 2015–17: 3.22* (1.61; 4.86) | |
| Spain—Castile-La Mancha | 1051.5 | 1045.0 | 1076.9 | 1096.6 | 1104.2 | 1109.3 | 1131.9 | 1148.7 | 1176.7 | 1208.1 | 2008–17: 1.53* (1.29; 1.77) | ||
| Spain—Catalonia | 1226.2 | 1257.1 | 1274.0 | 1289.2 | 1314.7 | 1340.8 | 1361.1 | 1392.0 | 1419.7 | 1442.4 | 2008–17: 1.80* (1.71; 1.88) | ||
| Spain—Community of Madrid | 1044.7 | 1066.1 | 1078.9 | 1091.8 | 1106.5 | 1126.3 | 1161.6 | 1182.5 | 1210.0 | 1228.4 | 2008–12: 1.40* (0.91; 1.88) | 2012–17: 2.17* (1.82; 2.51) | |
| Spain—Extremadura | 963.2 | 988.7 | 1034.4 | 1046.6 | 1071.6 | 1093.3 | 1106.7 | 1130.7 | 1125.5 | 1133.5 | 2008–10: 3.62* (1.07; 6.24) | 2010–15: 1.84* (1.04; 2.65) | 2015–17: 0.08 (−2.39; 2.60) |
| Spain—Galicia | 1007.0 | 1027.7 | 1046.7 | 1070.6 | 1097.3 | 1120.4 | 1144.0 | 1163.7 | 1180.0 | 1212.9 | 2008–17: 2.08* (1.99; 2.16) | ||
| Spain—Valencian region | 1274.8 | 1293.9 | 1310.6 | 1319.9 | 1345.5 | 1363.3 | 1427.7 | 1453.4 | 1506.2 | 1513.2 | 2008–17: 2.06* (1.72; 2.41) | ||
| Sweden | 906.6 | 921.2 | 936.8 | 953.2 | 951.3 | 959.3 | 971.9 | 977.7 | 992.0 | 1004.8 | 2008–17: 1.05* (0.91; 1.19) | ||
| The Netherlands | 877.2 | 907.2 | 924.5 | 938.4 | 953.0 | 971.4 | 984.7 | 997.0 | 1038.8 | 1029.9 | 2008–17: 1.79* (1.57; 2.02) | ||
| UK—England, Northern Ireland and Wales | 843.8 | 872.2 | 892.1 | 918.7 | 933.6 | 954.3 | 977.5 | 1003.8 | 1019.5 | 1031.9 | 2008–17: 2.27* (2.1; 2.43) | ||
| UK—Scotland | 841.5 | 854.0 | 861.8 | 862.8 | 881.4 | 887.3 | 904.3 | 928.2 | 940.5 | 961.2 | 2008–13: 1.05* (0.66; 1.43) | 2013–17: 2.02* (1.47; 2.57) | |
| All countries | 990.0 | 1014.8 | 1034.5 | 1052.8 | 1069.0 | 1088.2 | 1109.6 | 1129.4 | 1151.4 | 1166.8 | 2008–17: 1.82* (1.75; 1.89) | ||
This table shows the standardized prevalence pmp of patients receiving KRT for 25 countries and regions across Europe for each year between 2008 and 2017. The prevalence is reported per million population (pmp), and standardized using the age and sex distribution of the EU28 population in 2015. ‘All countries’ represents the overall standardized prevalence rates in all participating countries and regions together. To reflect the trends over time, the APC with corresponding 95% confidence interval is given for each time period. aTime periods are defined by a statistically significant joinpoint and could therefore differ between countries and regions. Bold numbers and an asterisk (*) indicate whether the APC was statistically significant (P < .05).
APC, annual percentage change; KRT, kidney replacement therapy; pmp, per million population.